Prognostic value of anti-IFI16 autoantibodies in pulmonary arterial hypertension and mortality in patients with systemic sclerosis

CONCLUSION: Anti-IFI16 autoantibodies were associated with isolated PAH and poorer overall survival. Anti-IFI16 autoantibodies could be used as a supplementary marker of lcSSc in SSc-seronegative patients and for identifying ACA-positive patients with worse clinical outcome.PMID:38302398 | DOI:10.1016/j.medcli.2023.11.020

Source: Medicina Clinica - February 1, 2024 Category: General Medicine Authors: Janire Perurena-Prieto Eduardo L Callejas-Moraga Mar ía T Sanz-Martínez Roger Colobran Alfredo Guill én-Del-Castillo Carmen P Sime ón-Aznar Source Type: research